BPH: The Patient Journey

Video content above is prompted by the following:

Condition Overview

BPH is a common age-related condition characterized by noncancerous enlargement of the prostate gland, which can significantly impact lower urinary tract symptoms and patient quality of life.

Patient Journey

Initial Presentation

• Typical patient profile: Aging male (typically 50+ years)
• Primary symptoms include:
  • Urinary frequency
  • Nocturia
  • Weak urinary stream
  • Difficulty initiating urination
  • Incomplete bladder emptying

Diagnostic Approach

• Comprehensive clinical assessment
• Digital rectal examination
• Prostate-specific antigen testing
• Urinary flow rate measurements
• Potential imaging studies (ultrasound, urodynamic studies)

Treatment Modalities

Pharmacological Interventions

• α-Blockers
  • Mechanism: Relaxes prostate and bladder neck muscles
  • Examples: tamsulosin, alfuzosin
  • Rapid symptom relief
  • Minimal impact on prostate size
• 5-α Reductase Inhibitors
  • Mechanism: Reduces prostate size by blocking testosterone conversion
  • Examples: finasteride, dutasteride
  • Slower onset of action
  • Beneficial for long-term prostate volume reduction
• Combination Therapy
  • Combining α-blockers and 5-α reductase inhibitors
  • Provides comprehensive symptom management
  • Recommended for patients with larger prostates
• Phosphodiesterase-5 Inhibitors
  • Example: Tadalafil
  • Dual benefit of treating BPH symptoms and erectile dysfunction
  • Lower dosage for BPH management